High glucose variability in children and young adults with type 1 diabetes (T1D) strongly predicted slowed nerve conduction velocity, a forerunner of diabetic peripheral neuropathy, in a recent study.

Researchers at The University of Texas MD Anderson Cancer Center have discovered that targeting a specific immune process ...

MONTREAL —Tirzepatide (Mounjaro, Eli Lilly), the dual gastric inhibitory polypeptide–glucagon-like peptide 1 (GIP–GLP-1) receptor agonist that has shown significant benefits in diabetes and obesity, ...

Please provide your email address to receive an email when new articles are posted on . Multiple diagnostic tools are necessary to assess diabetic peripheral neuropathy in patients. The choice of ...

Symptoms attributable to neuropathy were present in five (15%) patients. They were generally mild and not disabling. Seven (21%) patients had clinical signs of peripheral neuropathy. Sensory ...

WALTHAM, Mass.--(BUSINESS WIRE)--Regenacy Pharmaceuticals Inc, a clinical-stage biopharmaceutical company developing breakthrough treatments for diabetic and other peripheral neuropathies, announced ...

Handheld devices that can detect the telltale signs of peripheral neuropathy in people with diabetes could have another important function—predicting the risk that they will die within the next few ...

A hidden immune stress switch may be driving chemotherapy nerve pain and scientists have found a way to turn it off.

Peripheral neuropathy can develop as a complication of rheumatoid arthritis (RA). You may find similar treatments for both, but your doctor is best equipped to determine what medications may work for ...

Peripheral neuropathy symptoms often begin with pain or tingling in the hands and feet. Peripheral neuropathy is not common in children. Early diagnosis gives a better chance of reversing nerve damage ...